{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:12:55Z","timestamp":1786122775466,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82271967"],"award-info":[{"award-number":["No. 82271967"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010031","name":"Postdoctoral Research Foundation of China","doi-asserted-by":"publisher","award":["No. 2024M751466"],"award-info":[{"award-number":["No. 2024M751466"]}],"id":[{"id":"10.13039\/501100010031","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019349","name":"Nanjing Medical Science and Technique Development Foundation","doi-asserted-by":"publisher","award":["No. ZKX22038"],"award-info":[{"award-number":["No. ZKX22038"]}],"id":[{"id":"10.13039\/501100019349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-026-02831-5","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T10:44:08Z","timestamp":1770633848000},"page":"1651-1660","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Polyethylene glycol loxenatide improves cognitive and emotional performance in patients with type 2 diabetes: a 12-week multicenter clinical observational study"],"prefix":"10.1007","volume":"49","author":[{"given":"Xiao","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhe","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqing","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0830-6779","authenticated-orcid":false,"given":"Wenqing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"2831_CR1","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2019) Classification and diagnosis of diabetes: standards of medical care in Diabetes-2019. Diabetes Care 42(Suppl 1):S13\u2013s28","DOI":"10.2337\/dc19-S002"},{"issue":"4","key":"2831_CR2","doi-asserted-by":"publisher","first-page":"e70089","DOI":"10.1111\/1753-0407.70089","volume":"17","author":"X Meng","year":"2025","unstructured":"Meng X et al (2025) Risk Factors, pathological Changes, and potential treatment of Diabetes-Associated cognitive dysfunction. J Diabetes 17(4):e70089","journal-title":"J Diabetes"},{"issue":"3","key":"2831_CR3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2337\/dc23-1524","volume":"47","author":"N Feter","year":"2024","unstructured":"Feter N et al (2024) Leisure-Time physical activity May attenuate the impact of diabetes on cognitive decline in Middle-Aged and older adults: findings from the ELSA-Brasil study. Diabetes Care 47(3):427\u2013434","journal-title":"Diabetes Care"},{"key":"2831_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23168997","author":"Q Chen","year":"2022","unstructured":"Chen Q et al (2022) 12\/15-lipoxygenase regulation of diabetic cognitive dysfunction is determined by interfering with inflammation and cell apoptosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23168997","journal-title":"Int J Mol Sci"},{"key":"2831_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/nu15122738","author":"M Iwasa","year":"2023","unstructured":"Iwasa M et al (2023) Taxifolin suppresses inflammatory responses of high-glucose-stimulated mouse microglia by attenuating the TXNIP-NLRP3 axis. Nutrients. https:\/\/doi.org\/10.3390\/nu15122738","journal-title":"Nutrients"},{"key":"2831_CR6","doi-asserted-by":"crossref","unstructured":"Aghaei Z et al (2023) Neuroprotective Effect of Wharton\u2019s Jelly-Derived Mesenchymal Stem Cell-Conditioned Medium (WJMSC-CM) on Diabetes-Associated Cognitive Impairment by Improving Oxidative Stress, Neuroinflammation, and Apoptosis. Stem Cells Int 2023:7852394","DOI":"10.1155\/2023\/7852394"},{"key":"2831_CR7","doi-asserted-by":"publisher","first-page":"114830","DOI":"10.1016\/j.bbr.2023.114830","volume":"460","author":"H Yaribeygi","year":"2024","unstructured":"Yaribeygi H et al (2024) Empagliflozin alleviates diabetes-induced cognitive impairments by Lowering nicotinamide adenine dinucleotide phosphate oxidase-4 expression and potentiating the antioxidant defense system in brain tissue of diabetic rats. Behav Brain Res 460:114830","journal-title":"Behav Brain Res"},{"issue":"10248","key":"2831_CR8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G et al (2020) Dementia prevention, intervention, and care: 2020 report of the lancet commission. Lancet 396(10248):413\u2013446","journal-title":"Lancet"},{"issue":"4","key":"2831_CR9","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","volume":"27","author":"DJ Drucker","year":"2018","unstructured":"Drucker DJ (2018) Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab 27(4):740\u2013756","journal-title":"Cell Metab"},{"issue":"Pt A","key":"2831_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuropharm.2013.08.005","volume":"76","author":"PL McClean","year":"2014","unstructured":"McClean PL, H\u00f6lscher C (2014) Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP\/PS1 mice, a model of Alzheimer\u2019s disease. Neuropharmacology 76(Pt A):57\u201367","journal-title":"Neuropharmacology"},{"key":"2831_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jad.2022.12.089","volume":"324","author":"MK Seo","year":"2023","unstructured":"Seo MK et al (2023) Effects of liraglutide on depressive behavior in a mouse depression model and cognition in the probe trial of Morris water maze test. J Affect Disord 324:8\u201315","journal-title":"J Affect Disord"},{"issue":"5","key":"2831_CR12","doi-asserted-by":"publisher","first-page":"e612","DOI":"10.1038\/cddis.2013.139","volume":"4","author":"M Bomba","year":"2013","unstructured":"Bomba M et al (2013) Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals. Cell Death Dis 4(5):e612","journal-title":"Cell Death Dis"},{"issue":"5","key":"2831_CR13","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.2337\/dc21-2064","volume":"45","author":"H Cheng","year":"2022","unstructured":"Cheng H et al (2022) Enhancement of impaired olfactory neural activation and cognitive capacity by Liraglutide, but not Dapagliflozin or Acarbose, in patients with type 2 diabetes: A 16-Week randomized parallel comparative study. Diabetes Care 45(5):1201\u20131210","journal-title":"Diabetes Care"},{"issue":"7","key":"2831_CR14","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.2337\/dc18-2584","volume":"42","author":"Z Zhang","year":"2019","unstructured":"Zhang Z et al (2019) Olfactory dysfunction mediates adiposity in cognitive impairment of type 2 diabetes: insights from clinical and functional neuroimaging studies. Diabetes Care 42(7):1274\u20131283","journal-title":"Diabetes Care"},{"key":"2831_CR15","doi-asserted-by":"publisher","first-page":"1106868","DOI":"10.3389\/fendo.2023.1106868","volume":"14","author":"H Cai","year":"2023","unstructured":"Cai H et al (2023) Short-term effect of polyethylene glycol loxenatide on weight loss in overweight or obese patients with type 2 diabetes: an open-label, parallel-arm, randomized, metformin-controlled trial. Front Endocrinol (Lausanne) 14:1106868","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"2831_CR16","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1111\/dom.14163","volume":"22","author":"F Gao","year":"2020","unstructured":"Gao F et al (2020) Efficacy and safety of polyethylene glycol loxenatide as add-on to Metformin in patients with type 2 diabetes: A multicentre, randomized, double-blind, placebo-controlled, phase 3b trial. Diabetes Obes Metab 22(12):2375\u20132383","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"2831_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/dom.14198","volume":"23","author":"Y Shuai","year":"2021","unstructured":"Shuai Y et al (2021) Efficacy and safety of polyethylene glycol loxenatide monotherapy in type 2 diabetes patients: A multicentre, randomized, double-blind, placebo-controlled phase 3a clinical trial. Diabetes Obes Metab 23(1):116\u2013124","journal-title":"Diabetes Obes Metab"},{"key":"2831_CR18","doi-asserted-by":"publisher","first-page":"1235639","DOI":"10.3389\/fphar.2024.1235639","volume":"15","author":"Y Liu","year":"2024","unstructured":"Liu Y et al (2024) Efficacy of polyethylene glycol loxenatide for type 2 diabetes mellitus patients: a systematic review and meta-analysis. Front Pharmacol 15:1235639","journal-title":"Front Pharmacol"},{"issue":"7","key":"2831_CR19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15(7):539\u2013553","journal-title":"Diabet Med"},{"key":"2831_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411301","author":"MC Pelle","year":"2023","unstructured":"Pelle MC et al (2023) Potential role of glucagon-like peptide-1 receptor agonists in the treatment of cognitive decline and dementia in diabetes mellitus. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241411301","journal-title":"Int J Mol Sci"},{"key":"2831_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/nu15010038","author":"F Yang","year":"2022","unstructured":"Yang F et al (2022) Glucagon-like peptide 1 receptor activation inhibits microglial pyroptosis via promoting mitophagy to alleviate depression-like behaviors in diabetic mice. Nutrients. https:\/\/doi.org\/10.3390\/nu15010038","journal-title":"Nutrients"},{"key":"2831_CR22","doi-asserted-by":"publisher","first-page":"106320","DOI":"10.1016\/j.phrs.2022.106320","volume":"182","author":"G Bendotti","year":"2022","unstructured":"Bendotti G et al (2022) The anti-inflammatory and immunological properties of GLP-1 receptor agonists. Pharmacol Res 182:106320","journal-title":"Pharmacol Res"},{"issue":"6","key":"2831_CR23","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.cmet.2024.05.001","volume":"36","author":"M Ben Nasr","year":"2024","unstructured":"Ben Nasr M et al (2024) Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule. Cell Metab 36(6):1302\u20131319e12","journal-title":"Cell Metab"},{"key":"2831_CR24","doi-asserted-by":"crossref","unstructured":"Gitto M et al (2025) GLP-1 receptor agonists and coronary plaques regression in diabetic patients after acute coronary syndromes. Acta Diabetol, Epub ahead of print","DOI":"10.1007\/s00592-025-02606-z"},{"issue":"5","key":"2831_CR25","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.bbadis.2016.04.017","volume":"1863","author":"S Pugazhenthi","year":"2017","unstructured":"Pugazhenthi S, Qin L, Reddy PH (2017) Common neurodegenerative pathways in obesity, diabetes, and alzheimer\u2019s disease. Biochim Biophys Acta Mol Basis Dis 1863(5):1037\u20131045","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2831_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.freeradbiomed.2021.09.006","volume":"176","author":"E Barone","year":"2021","unstructured":"Barone E et al (2021) The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and alzheimer disease. Free Radic Biol Med 176:16\u201333","journal-title":"Free Radic Biol Med"},{"key":"2831_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212366","author":"FC Pignalosa","year":"2021","unstructured":"Pignalosa FC et al (2021) Diabetes and cognitive impairment: a role for glucotoxicity and dopaminergic dysfunction. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms222212366","journal-title":"Int J Mol Sci"},{"key":"2831_CR28","doi-asserted-by":"publisher","first-page":"109653","DOI":"10.1016\/j.intimp.2022.109653","volume":"115","author":"MH Lin","year":"2023","unstructured":"Lin MH et al (2023) The GLP-1 receptor agonist exenatide ameliorates neuroinflammation, locomotor activity, and anxiety-like behavior in mice with diet-induced obesity through the modulation of microglial M2 polarization and downregulation of SR-A4. Int Immunopharmacol 115:109653","journal-title":"Int Immunopharmacol"},{"key":"2831_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/biology9110348","author":"JL Yang","year":"2020","unstructured":"Yang JL et al (2020) The neurotrophic function of glucagon-like peptide-1 promotes human neuroblastoma differentiation via the PI3K-AKT axis. Biology (Basel). https:\/\/doi.org\/10.3390\/biology9110348","journal-title":"Biology (Basel)"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02831-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-02831-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02831-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T12:25:04Z","timestamp":1786105504000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-026-02831-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["2831"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-02831-5","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the authors have nothing to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interests and commercial relationships with others.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}